Literature DB >> 7673962

Signal intensity on MRI of basal ganglia in multiple sclerosis.

J Grimaud1, J Millar, J W Thorpe, I F Moseley, W I McDonald, D H Miller.   

Abstract

It has been reported that a relative reduction in signal intensity on T2 weighted MRI may be seen in the basal ganglia of patients with multiple sclerosis and furthermore that this is due to excessive iron deposition. The basal ganglia are, however, rarely involved clinically or pathologically in multiple sclerosis, casting some doubt on this finding. Therefore MRI was carried out in 46 patients with definite multiple sclerosis and 42 age matched controls. Contiguous, 5 mm thick axial dual echo spin-echo images of the brain were obtained on a 1.5T imager. Visual rating scales were used to measure the lesion load as well as the signal intensity of the globus pallidus, putamen, caudate nucleus, substantia nigra, red nucleus, and thalamus. There was a mild degree of low signal intensity in the patient group in the thalamus only. The signal intensity of the thalamus and putamen was never lower than that of the globus pallidus. Low signal in the basal ganglia is rarely, if ever, found in multiple sclerosis and is not a useful radiological sign.

Entities:  

Mesh:

Year:  1995        PMID: 7673962      PMCID: PMC486036          DOI: 10.1136/jnnp.59.3.306

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  The effect of age on the non-haemin iron in the human brain.

Authors:  B HALLGREN; P SOURANDER
Journal:  J Neurochem       Date:  1958-10       Impact factor: 5.372

2.  Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths.

Authors:  A Bizzi; R A Brooks; A Brunetti; J M Hill; J R Alger; R S Miletich; T L Francavilla; G Di Chiro
Journal:  Radiology       Date:  1990-10       Impact factor: 11.105

3.  Does signal-attenuation on high-field T2-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels.

Authors:  D J Brooks; P Luthert; D Gadian; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

4.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

5.  Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution.

Authors:  J M Hill; M R Ruff; R J Weber; C B Pert
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

6.  Trace element concentration in human brain. Activation analysis of cobalt, iron, rubidium, selenium, zinc, chromium, silver, cesium, antimony and scandium.

Authors:  A Höck; U Demmel; H Schicha; K Kasperek; L E Feinendegen
Journal:  Brain       Date:  1975-03       Impact factor: 13.501

7.  Deep gray matter hypointensity patterns with aging in healthy adults: MR imaging at 1.5 T.

Authors:  W J Milton; S W Atlas; F J Lexa; P D Mozley; R E Gur
Journal:  Radiology       Date:  1991-12       Impact factor: 11.105

8.  T2 estimates in healthy and diseased brain tissue: a comparison using various MR pulse sequences.

Authors:  R H Darwin; B P Drayer; S J Riederer; H Z Wang; J R MacFall
Journal:  Radiology       Date:  1986-08       Impact factor: 11.105

9.  T2 values in the human brain: comparison with quantitative assays of iron and ferritin.

Authors:  J C Chen; P A Hardy; M Clauberg; J G Joshi; J Parravano; J H Deck; R M Henkelman; L E Becker; W Kucharczyk
Journal:  Radiology       Date:  1989-11       Impact factor: 11.105

10.  Iron deposits surrounding multiple sclerosis plaques.

Authors:  W Craelius; M W Migdal; C P Luessenhop; A Sugar; I Mihalakis
Journal:  Arch Pathol Lab Med       Date:  1982-08       Impact factor: 5.534

View more
  12 in total

Review 1.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

2.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

3.  Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis.

Authors:  M Filippi; C Tortorella; M Rovaris; M Bozzali; F Possa; M P Sormani; G Iannucci; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

4.  Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation.

Authors:  G Iannucci; C Tortorella; M Rovaris; M P Sormani; G Comi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

5.  Neuroradiological evaluation of demyelinating disease.

Authors:  Jan-Mendelt Tillema; Istvan Pirko
Journal:  Ther Adv Neurol Disord       Date:  2013-07       Impact factor: 6.570

6.  1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis.

Authors:  C A Davie; G J Barker; A J Thompson; P S Tofts; W I McDonald; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-12       Impact factor: 10.154

7.  Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging.

Authors:  Y Ge; J H Jensen; H Lu; J A Helpern; L Miles; M Inglese; J S Babb; J Herbert; R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

Review 8.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

Review 9.  Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis.

Authors:  David H Miller
Journal:  NeuroRx       Date:  2004-04

10.  Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup?

Authors:  C A Davie; N C Silver; G J Barker; P S Tofts; A J Thompson; W I McDonald; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.